Virax Biolabs Group Limited (NASDAQ:VRAX) announced on Tuesday that it had signed a Research Services Agreement (RSA) with Emory University's Center for the Advancement of Diagnostics for a Just Society (ADJUST Center) to conduct clinical studies of ViraxImmune.
ViraxImmune is a proprietary T cell testing technology to evaluate a patient's immune response profile. Unlike conventional antibody testing, it assesses T cell reactivity to provide a more comprehensive picture of immune health in chronic and post-viral conditions.
